294
Participants
Start Date
May 17, 2023
Primary Completion Date
September 13, 2023
Study Completion Date
September 13, 2023
alteplase
Intravenous thrombolysis with alteplase (0.9 mg/kg, maximum 90 mg) with 10% of the dose given as a bolus followed by an infusion lasting 60 minutes.
Alteplase + possible complementary IVT with tenecteplase
Intravenous thrombolysis with alteplase (0.9 mg/kg, maximum 90 mg, with 10% of the dose given as a bolus followed by an infusion lasting 60 minutes) and depending on the MRI-2 results, an additional IVT with tenecteplase (0.25mg/kg, maximum 25 mg, with 100% of the dose given as a bolus) could be given in case of persistent occlusion and with no contraindication according to the study protocol.
Centre Hospitalier Sud Francilien, Corbeil-Essonnes
Centre Hospitalier Sud Francilien
OTHER